What targeted drugs are better for lung cancer brain metastasis? These drugs all have good therapeutic effects

The targeted drugs that lung cancer patients with brain metastases need to take include first-generation gefitinib and Tarceva; second-generation icotinib; third-generation osimertinib, etc., all of which have good therapeutic effects.

We know that lung cancer is a very harmful disease, which brings serious mental distress to patients. So, what targeted drugs are good for lung cancer brain metastasis? Let's find out below!
Lung cancer has severe brain metastasis. In this case, the selection of targeted drugs often needs to be based on the patient's specific pathological type.
First of all, currently, the more mature targeted therapy in my country is often lung adenocarcinoma. If lung adenocarcinoma patients have various gene mutations, then in this case, they can choose a variety of targeted therapeutic drugs for treatment. There are many types of targeted drugs available for patients to choose from, such as the first-generation targeted drugs gefitinib and Tarceva, the second-generation targeted drug icotinib, the third-generation targeted drug osimertinib, and so on.
The drug osimertinib is generally more suitable for patients with T790M mutations that are resistant to first- and second-generation targeted drugs.
If the patient's lung cancer does not have a clear gene mutation, or if it is a squamous cell carcinoma patient, then the probability of gene mutation is often very low, and anlotinib can be chosen for treatment. However, there is still no mature targeted drug available for the treatment of patients with small cell lung cancer.